Create Medicines Deal History & Licensing Activity
Create Medicines is a life sciences headquartered in US. Over the past three years, Create Medicines has been involved in 2 licensing and acquisition transactions, with a primary focus on CAR-T (4 deals). The company currently has 3 active clinical trials, primarily in Immunology.
Deals (12mo)
2
Active Trials
3
Top Modality
CAR-T
Focus Area
Immunology
Create Medicines Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Create Medicines in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CRT-403, CRT-401, CD19 × BCMA RetroT program | WestGene Biopharma | CAR-T | Preclinical | collaboration | Aug 28, 2026 |
| CAR products platform | Monash University | CAR-T | Discovery | collaboration | Jul 31, 2026 |
Create Medicines Pipeline Focus
Therapeutic areas and modalities where Create Medicines is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Create Medicines Clinical Pipeline
Create Medicines has 3 active clinical trials across 2 development phases.
2
Phase 1
1
Phase 1/2
See How Your Asset Matches Create Medicines's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
CAR-T Benchmarks
Upfront, milestone, and royalty benchmarks for car-t deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Create Medicines Licensing & Deal Activity
Create Medicines is a life sciences company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Create Medicines ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Create Medicines include Immunology (2 deals and trials), Other (2 deals and trials), Solid Tumors (2 deals and trials), and Autoimmune (1 deal and trial). In terms of modality, Create Medicines has shown particular interest in car-t.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Create Medicines and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Create Medicines's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.